Thus, the lack of IL-10 expression under the TLR7 signaling and the constitutive upregulation of IL-23 in DCs could result in the exacerbation of imiquimod-induced psoriasis-like skin inflammation. This evidence concerns the gene TLR7 and dermatitis.